Aviragen Therapeutics (AVIR) Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2

Go back to Aviragen Therapeutics (AVIR) Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2
(NASDAQ: AVIR) Delayed: 22.02 +0.92 (4.36%)
Previous Close $21.10    52 Week High $2.00 
Open $21.15    52 Week Low $1.15 
Day High $22.33    P/E N/A 
Day Low $19.70    EPS $0.00 
Volume 983,900